 |
|
Polymyalgia Rheumatica Without Significantly Increased Erythrocyte Sedimentation RateA More Benign Syndrome
Miguel A. González-Gay, MD, PhD;
Vicente Rodríiguez-Valverde, MD;
Ricardo Blanco, MD;
Jose L. Fernández-Sueiro, MD;
Jose Armona, MD;
Manuel Figueroa, MD;
Victor M. Martínez-Taboada, MD
Arch Intern Med. 1997;157(3):317-320.
Abstract
| |
Background
An erythrocyte sedimentation rate (ESR) of at least 40 mm/h is considered an important requisite for the diagnosis of polymyalgia rheumatica (PMR). However, the relative frequency and clinical features of PMR in patients without a significantly increased ESR are unclear.
Methods
We performed a retrospective study of patients diagnosed as having PMR at the rheumatology divisions of 3 teaching hospitals. The diagnosis of PMR was established, regardless of the ESR, in 201 consecutive patients fulfilling the following criteria: (1) age 50 years or older, (2) severe proximal pain for more than 1 month in at least 2 of 3 areas: neck, shoulder, and/or pelvic girdles, and (3) rapid resolution of the syndrome while taking low-dose prednisone. Patients with giant cell arteritis were previously excluded from the study. The frequency and clinical features of patients with PMR and an ESR lower than 40 mm/h were analyzed. A comparative study between these patients and those with high ESRs was performed.
Results
An ESR lower than 40 mm/h was found in 41 patients (20.4%). These patients were younger (P=.02), were more frequently men (P=.006), and experienced a lower frequency of fever (P=.003) and weight loss (P=.07). Furthermore, these patients were characterized by an absence of anemia (P=.002) and a lower frequency of abnormal protein electrophoresis results (P<.001). Otherwise, their clinical syndrome, response to therapy, and frequency of relapses were similar to those of patients with classic PMR. In the entire population of 201 patients, the ESR was related to the length of treatment, number of areas involved, presence of fever, weight loss, and laboratory test result abnormalities, but it was unrelated to the duration of the illness prior to diagnosis.
Conclusions
It is not uncommon to find a patient with PMR with an ESR lower than 40 mm/h. This syndrome is more frequent in men and it is clinically less severe than the classic form of PMR. Its recognition will allow these patients to benefit from an effective treatment with low-dose corticosteroids.
Arch Intern Med. 1997;157:317-320
Author Affiliations
From the Divisions of Rheumatology, Hospital Xeral-Calde, Lugo (Dr Gonzalez-Gay), Hospital Universitario M. Valdecilla and Faculty of Medicine, Universidad de Cantabria, Santander (Drs Rodríguez-Valverde, Blanco, Fernández-Sueiro, Armona, and Martínez-Taboada), and Hospital Nuestra Señora de Aránzazu, San Sebastián (Dr Figueroa), Spain.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A disease activity score for polymyalgia rheumatica
Leeb and Bird
Ann Rheum Dis 2004;63:1279-1283.
ABSTRACT
| FULL TEXT
Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis
Lopez-Hoyos et al.
Ann Rheum Dis 2004;63:54-60.
ABSTRACT
| FULL TEXT
EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)
Leeb et al.
Ann Rheum Dis 2003;62:1189-1194.
ABSTRACT
| FULL TEXT
Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy
Martinez-Taboada et al.
Rheumatology (Oxford) 2003;42:1055-1061.
ABSTRACT
| FULL TEXT
Limited value of elevated erythrocyte sedimentation rate as an indicator of malignancy
Monig et al.
Fam Pract 2002;19:436-438.
ABSTRACT
| FULL TEXT
Polymyalgia rheumatica: pitfalls in diagnosis
Siebert et al.
JRSM 2001;94:242-244.
FULL TEXT
Rheumatology: 2. What laboratory tests are needed?
Shojania
CMAJ 2000;162:1157-1163.
ABSTRACT
| FULL TEXT
Erythrocyte Sedimentation Rate and C-Reactive Protein in the Diagnosis of Polymyalgia Rheumatica
Cantini et al.
ANN INTERN MED 1998;128:873-874.
FULL TEXT
Thrombocytosis in Polymyalgia Rheumatica: An Additional Diagnostic Criterion and Possible Risk Factor for Ischemic Complications?
Harten et al.
Arch Intern Med 1998;158:95-97.
FULL TEXT
Polymyalgia Rheumatica vs Rheumatoid Arthritis in the Elderly
Gonzalez-Gay and Garcia-Porrua
Arch Intern Med 1997;157:2016-2016.
ABSTRACT
|
